Metraipolis › archive › dc_ddab91c0f569

Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile" — Europe PMC PMID:41718487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41718487
DOI
10.1128/aac.00887-25
License (as archived)
solo-consultazione
Archived
2026-11-05T14:41:13.266Z
SHA-256 of the archived text
54f8f91a7273acf0329c184afaef3d90e6effc21bfd6fcc5b55f6b90260ca79d
Stable URL of this page
https://metraipolis.com/documento/dc_ddab91c0f569

How to cite

Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile" — Europe PMC PMID:41718487 — Europe PMC (en), https://europepmc.org/article/MED/41718487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddab91c0f569 (Metraipolis archive dc_ddab91c0f569, sha256 54f8f91a7273acf0329c184afaef3d90e6effc21bfd6fcc5b55f6b90260ca79d)
BibTeX
@misc{dcddab91c0f569,
  title = {Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile" — Europe PMC PMID:41718487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41718487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddab91c0f569; sha256 54f8f91a7273acf0329c184afaef3d90e6effc21bfd6fcc5b55f6b90260ca79d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41718487. Agents can read the archived copy with the MCP tool read_document.